Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

38.1K
Overview
38.1K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

143
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

Cancer research communications·2026
Same author

Tiered Approach to Clonidine Dosing to Prevent Dexmedetomidine Withdrawal in Children: A Prospective Pre and Post Interventional Cohort Study.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Preliminary development and content validation of mopet-A multidomain oncology pain assessment tool for cancer care setting.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Nationwide Survey on Endoscopic Submucosal Dissection for Early Gastric Cancer in Korea: Results From the Korean College of <i>Helicobacter</i> and Upper Gastrointestinal Research (KCHUGR) 2023 Survey.

Journal of gastric cancer·2026
Same author

Real-World Survival Outcomes and Prognostic Factors in De Novo Stage IV Urothelial Bladder Cancer: A 13-Year Retrospective Cohort Study.

Clinical genitourinary cancer·2026
Same author

SEVERE BACTERIAL BRONCHOPNEUMONIA IN A GROUP OF ORPHANED AMERICAN BLACK BEARS (<i>URSUS AMERICANUS</i>) IN EASTERN TENNESSEE, USA.

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians·2026

Related Experiment Video

Updated: May 5, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.9K

Readmission Rate After Methicillin-Resistant Staphylococcus aureus (MRSA) Infection: A Retrospective Study.

Riddhi Patel1, Sun Moon Kim1, Yarl Dhayaparan2

  • 1Internal Medicine, Lake Erie College of Osteopathic Medicine, Yonkers, USA.

Cureus
|April 9, 2025
PubMed
Summary

High readmission rates for Methicillin-resistant Staphylococcus aureus (MRSA) patients are linked to increased morbidity. Nearly half of 30-day readmissions were for infections, while the other half were for worsening comorbidities.

Keywords:
30-day readmissioncolonizationcomorbidity controlhealthcare burdenhospital readmission rateinfectious disease controlmethicillin resistant staphylococcus aureus (mrsa)

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.6K
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.0K

Related Experiment Videos

Last Updated: May 5, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.9K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

15.6K
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.0K

Area of Science:

  • Infectious Diseases
  • Hospital Readmission Studies
  • Clinical Outcomes

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant burden on healthcare systems.
  • Effective eradication of MRSA remains challenging despite numerous antibiotic options.
  • Limited research exists on post-discharge readmission rates for MRSA patients.

Purpose of the Study:

  • To determine the 30-day readmission rate for patients hospitalized with MRSA.
  • To analyze the 90-day readmission rates for MRSA patients.
  • To identify reasons for hospital readmissions in MRSA patients.

Main Methods:

  • Retrospective chart review of electronic medical records and billing data.
  • Inclusion criteria: patients aged >18, admitted to a US center, with positive MRSA diagnosis (2014-2024).
  • Data collected: demographics, comorbidities, length of stay, readmission diagnoses; analyzed using Microsoft Excel.

Main Results:

  • 17.32% of 127 MRSA patients were readmitted within 30 days, with 54.17% due to infection and 45.83% due to comorbidities.
  • 27.56% of patients were readmitted within 90 days, with 44.44% for infection and 44.44% for comorbidities.
  • Average 30-day readmission ratio was 1.09/patient; average 90-day ratio was 1.5/patient.

Conclusions:

  • High readmission rates for MRSA patients are associated with increased morbidity.
  • Infectious processes and exacerbation of comorbidities are primary drivers of 30-day readmissions.
  • Understanding these factors is crucial for improving post-discharge care and reducing readmission rates.